Jethro Holter
Presidente presso GENETIC ANALYSIS
Patrimonio netto: 189 162 $ in data 30/06/2024
Profilo
Jethro Holter is currently the Chief Executive Officer at Biotec BetaGlucans AS.
He is also the Chairman at Genetic Analysis AS and the Managing Director at ArcticZymes AS.
Previously, he served as the Chief Executive Officer at ArcticZymes Technologies ASA from 2019 to 2023.
He also worked as the Director of Research & Development at Mole Genetics AS.
Dr. Holter holds a doctorate degree from the University of Cardiff.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2023 | 80 564 ( 0.16% ) | 189 162 $ | 30/06/2024 |
Posizioni attive di Jethro Holter
| Società | Posizione | Inizio |
|---|---|---|
| GENETIC ANALYSIS | Presidente | 14/05/2024 |
ArcticZymes AS
 ArcticZymes AS Medical SpecialtiesHealth Technology Part of ArcticZymes Technologies ASA, ArcticZymes AS is a Norwegian company that manufactures diagnostic substances. The company is based in Tromsø, Norway. Jethro Holter has been the CEO of the company since 2015. | Amministratore Delegato | 01/01/2015 |
Biotec BetaGlucans AS
 Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | Amministratore Delegato | - |
Precedenti posizioni note di Jethro Holter
| Società | Posizione | Fine |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Amministratore Delegato | 18/09/2023 |
Mole Genetics AS
 Mole Genetics AS BiotechnologyHealth Technology Mole Genetics AS manufactures and sells instruments & pre-filled reagent cartridges for genetic research. The firm product GeneMole is used for automation of DNA and RNA extraction system and MoleStrips is used for prefilled disposable reagent strips. The company was founded by Ole Jesper Dahlberg, Frank Larsen, Arne Deggerdal, and Tone Yrvum in June 2005 and is headquartered in Lysaker, Norway. | Corporate Officer/Principal | - |
Formazione di Jethro Holter
| University of Cardiff | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| GENETIC ANALYSIS | Health Technology |
| Aziende private | 3 |
|---|---|
ArcticZymes AS
ArcticZymes AS Medical SpecialtiesHealth Technology Part of ArcticZymes Technologies ASA, ArcticZymes AS is a Norwegian company that manufactures diagnostic substances. The company is based in Tromsø, Norway. Jethro Holter has been the CEO of the company since 2015. | Health Technology |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | Health Technology |
Mole Genetics AS
Mole Genetics AS BiotechnologyHealth Technology Mole Genetics AS manufactures and sells instruments & pre-filled reagent cartridges for genetic research. The firm product GeneMole is used for automation of DNA and RNA extraction system and MoleStrips is used for prefilled disposable reagent strips. The company was founded by Ole Jesper Dahlberg, Frank Larsen, Arne Deggerdal, and Tone Yrvum in June 2005 and is headquartered in Lysaker, Norway. | Health Technology |
- Borsa valori
- Insiders
- Jethro Holter
